Amin A. Nomeir
Alexion Pharma (Switzerland)(CH)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Analytical Chemistry and Chromatography, Drug Transport and Resistance Mechanisms, Computational Drug Discovery Methods, Hepatitis C virus research
Most-Cited Works
- → Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor(2010)557 cited
- Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.(1998)
- → The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America(2009)305 cited
- → Discovery of MK‐8742: An HCV NS5A Inhibitor with Broad Genotype Activity(2013)196 cited
- → Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases(2010)175 cited
- → Cassette‐accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery(2001)151 cited
- →